June 17, 2013
Takeda Pharmaceutical announced on June 13 that the company and Pfizer Inc. have settled a US patent lawsuit with two generic makers for a total of US$2.15 billion for the peptic ulcer treatment Protonix (pantoprazole). Under the settlement, Teva Pharmaceutical...read more